Health
Expert panel provides guidance for optimized design of early drug trials for Alzheimer’s, related dementias – News-Medical.Net
An expert panel convened by the Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) provides guidance on best…
An expert panel convened by the Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) provides guidance on best practices for the design of early drug trials for Alzheimer’s disease, frontotemporal degeneration (FTD), and other neurodegenerative dementias. Their guidance was published in the May 18, 2021 issue of Neurology®, the medical journal of the American Academy of Neurology (“Value-Generating Exploratory Trials in Neurodegenerative Dementias”).
…
-
Noosa News17 hours agoHow Lily Steele-Park took her rapist to court and won
-
General23 hours agoRush to buy homes before rate cuts send prices soaring
-
Business22 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business19 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025